Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2025-12-29 @ 5:46 AM
Study NCT ID:
NCT00433433
Status:
UNKNOWN
Last Update Posted:
2021-02-03
First Post:
2007-02-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma
Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-10
Start Date Type:
ACTUAL
Primary Completion Date:
2011-12
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2007-02-08
First Submit QC Date:
None
Study First Post Date:
2007-02-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-02
Last Update Post Date:
2021-02-03
Last Update Post Date Type:
ACTUAL